Servicios para Profesionales

Libro, Tomo 1, 1984-2005 LIBRO, Tomo 2, 2006-2016



  1. McCrance RA. Osteomalacia with Looser´s nodes (milkman´syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years. Q J Med 1947; 16:33-46.
  2. Larsson T, Zahradnik R, Lavigne J, Ljunggren Ö, Jüppner H, Jonsson K. Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia. Eur J Endocrinol 2003; 148:269-276.
  3. Fukumoto S, Yamashita T. Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be the phosphatonin. Curr Opin Nephrol Hypertens 2002, 11:385-9.
  4. Sommer S, Berndt T, Craig T, Kumar R. The phosphatonins and the regulation of phosphate transport and vitamin D metabolism. J Steroid Biochem 2007; 103: 497-503.
  5. Jan de Beur SM. Tumor-induced osteomalacia. JAMA 2005; 294:1260-7.
  6. Jan de Beur SM. Tumor-induced osteomalacia. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. 6th edition. Philadelphia, Pa: Lippincot Williams & Wilkins; 2006:345-50.
  7. Dupond JL, Mahammedi H, Prié D, Collin F, Gil H, Blagosklonov O, Ricbourg B, Meaux-Ruault N, Kantelip B. Oncogenic Osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT SCAN for the diagnosis and follow up in one case. Bone 2005; 36:375-378.
  8. Roarke MC, Nguyen BD. PET/CT Localization of phosphaturic mesenchymal neoplasm causing tumor-induced osteomalacia. Clin Nuc Med 2007; 32:300-301.
  9. Hesse E, Moessinger E, Rosenthal H, Laenger F, Brabant G, Petrich T, Gratz KF, Bastian L. Oncogenic Osteomalacia: Exact tumor localization by co-registration of emission and computed tomography. Clinical Vignette. J Bone Miner Res 2007; 22:158-162.

- Introducción
- Caso Clínico
- Conclusiones
- Bibliografía